Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma. - Shah B; Challagulla S; Xu S; Williams R; Ren S; Srivastava T; Gautam R; Yang K; Saba NS; Tam CS (Leukemia & lymphoma, 2025)